Alzheimer Dementia (AD) Completed Phase 4 Trials for Rivastigmine (DB00989)

Also known as: Alzheimer's Dementia / Alzheimer Dementia

IndicationStatusPhase
DBCOND0078271 (Alzheimer Dementia (AD))Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01585272Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Alzheimer's DementiaTreatment